Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 81 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $497,307 | -21.3% | 91,249 | -1.9% | 0.03% | -11.1% |
| Q2 2023 | $631,619 | +40.9% | 93,022 | +4.0% | 0.04% | +44.0% |
| Q1 2023 | $448,295 | +5.5% | 89,480 | +2.7% | 0.02% | +4.2% |
| Q4 2022 | $424,999 | -67.5% | 87,090 | -3.9% | 0.02% | -68.4% |
| Q3 2022 | $1,307,000 | -6.0% | 90,665 | -1.3% | 0.08% | +13.4% |
| Q2 2022 | $1,390,000 | +29.4% | 91,898 | +1.7% | 0.07% | +55.8% |
| Q1 2022 | $1,074,000 | -21.5% | 90,375 | +7.1% | 0.04% | -12.2% |
| Q4 2021 | $1,368,000 | -51.7% | 84,395 | -15.0% | 0.05% | -53.3% |
| Q3 2021 | $2,834,000 | -13.4% | 99,291 | +2.6% | 0.10% | -9.5% |
| Q2 2021 | $3,271,000 | +7.1% | 96,774 | -4.2% | 0.12% | +16.0% |
| Q1 2021 | $3,055,000 | -38.9% | 101,028 | +0.0% | 0.10% | -43.2% |
| Q4 2020 | $5,000,000 | +37.7% | 100,994 | +6.8% | 0.18% | +20.5% |
| Q3 2020 | $3,630,000 | +30.6% | 94,567 | +47.0% | 0.15% | +22.7% |
| Q2 2020 | $2,779,000 | +67.3% | 64,326 | +1.1% | 0.12% | +28.0% |
| Q1 2020 | $1,661,000 | +34.4% | 63,628 | +60.8% | 0.09% | +121.4% |
| Q4 2019 | $1,236,000 | – | 39,566 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $932,939 | 3.08% |
| Sofinnova Investments, Inc. | 2,194,278 | $10,708,077 | 0.64% |
| Artal Group S.A. | 400,000 | $1,952 | 0.11% |
| Polar Capital Holdings Plc | 1,991,929 | $9,720,614 | 0.08% |
| ASHFORD CAPITAL MANAGEMENT INC | 98,870 | $482,486 | 0.08% |
| Soleus Capital Management, L.P. | 87,182 | $425,448 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 99,160 | $484 | 0.06% |
| Cormorant Asset Management, LP | 150,000 | $732 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 48,233 | $235,377 | 0.04% |
| XTX Topco Ltd | 38,574 | $188,241 | 0.04% |